
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Author(s) -
Matthew J. Ellis,
Vera J. Suman,
Jeremy Hoog,
Rodrigo Gonçalves,
Souzan Sanati,
Chad J. Creighton,
Katherine DeSchryver,
Erika Crouch,
Amy Brink,
Mark W. Watson,
Jingqin Luo,
Yu Tao,
Michael Barnes,
Mitchell Dowsett,
G. Thomas Budd,
Eric P. Winer,
Paula Silverman,
Laura J. Esserman,
Lisa A. Carey,
Cynthia X. Ma,
Gary Unzeitig,
Timothy Pluard,
Pat W. Whitworth,
Gildy Babiera,
Julia Guenther,
Zoneddy Dayao,
David M. Ota,
A. Marilyn Leitch,
John A. Olson,
D. Craig Allred,
Kelly K. Hunt
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/4pwv-v868
Subject(s) - medicine , breast cancer , oncology , aromatase inhibitor , chemotherapy , aromatase , randomized controlled trial , cancer , gynecology